Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bullish
Freee KK
Watchlist
Freee: Our 2021 Conviction Pick Grew 50% in 2QFY06/21 and That Should Continue
Equity Bottom-Up
366 Views
10 Feb 2021 11:05
Freee reported its 2QFY06/21 results today which saw 51.3% YoY growth in revenues while operating losses for the quarter dropped to 18% of revenues from 38% in 2QFY06/20.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 5-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Equity Bottom-Up
South Korea
Japan
Event-Driven
China
India
Equity Derivatives
Asia Event-Driven
Unpaywalled Insights
Trending Insights
More »
HEW: Geopolitics Blow Hot And Warm
Zhejiang Sanhua Intelligent Controls (2050 HK): Big Raise Supported by Cornerstones
Singapore Airlines - Confluence of events (SIA SP, CP SGD7.03, HOLD, TP SGD6.85, Airlines)
Key Markets Tactical Outlooks After Israel Strike on Iran
Wuxi Biologics Placement - Smaller Deal than Previous as Last Didn’t Do Well, Overhang Remain
Top Unpaywalled Insights
More »
[IO Technicals 2025/24] Downward Momentum Lingers
China A-Share Consumer Staples: An Analysis of the Opportunities Ahead
Bearishness Persist in Soybeans Despite Rebound Hopes
Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
[IO Technicals 2025/23] Bearish Momentum Persists
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
ORo 4Q2020 Results: Strong Finish to the Year and There Is a Buyback
15 Feb 2021
SciClone Pharmaceutical IPO: Future Prospects for Zadaxin Troubling
15 Feb 2021
Japan Small Cap Growth - Freee or Money Forward?
11 Feb 2021
Freee: Our 2021 Conviction Pick Grew 50% in 2QFY06/21 and That Should Continue
10 Feb 2021
Joinn Laboratories IPO: Pioneer of Commercial GLP Laboratories in China Shows Promise
10 Feb 2021
New Horizon Health IPO Valuation: Healthy Valuation
08 Feb 2021
2021 High Conviction - Rapid User Growth Will Set You Freee From Losses
29 Nov 2020
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x